Common Antimicrobial May Raise Risk of Colon Disease
Triclosan, a common antimicrobial used in toothpastes and other products, may raise the risk of gut inflammation and colorectal cancer, according to a preliminary animal study.
Browsing: "Cancer"
Rare Bacteria Boosts Immunotherapy in Prostate Cancer
A unique bacterial strain isolated from a patient with pelvic pain could be the key to treating prostate cancer with immunotherapy, according to a study published in Nature Communications.
Resident Investigates Radiation Therapy Benefit in Breast Cancer
The presence of cancer cells in the bloodstream of patients with early-stage breast cancer may be predictive of benefit from radiotherapy after surgery, according to a new Northwestern Medicine study.
Resetting the Epigenetic Balance for Cancer Therapy
Northwestern Medicine scientists have discovered an epigenetic imbalance that can lead to cancer, and used these findings to inhibit tumors in models.
A New Weapon Against Cancer Metastasis
Northwestern Medicine scientists have discovered a new compound that halts the spread of multiple types of cancer cells.
Enzyme Blocker Stops Growth of Deadly Brain Tumor
Scientists discovered the regulatory role of the enzyme CDK5 in an aggressive form of brain cancer and successfully halted tumor growth by inhibiting it.
Evaluating Drug Regimens for High-Risk Prostate Cancer
The addition of a chemotherapy drug to adjuvant hormone therapy did not improve survival for patients with high-risk prostate cancer, according to a new study.
Precision Pathologist
New chair Daniel Brat, MD, PhD, is spearheading transformations in pathology, a field that’s rapidly evolving in parallel with advances in precision medicine and a trend toward sub-specialization.
Genome Analysis Identifies Mutations in Pediatric Cancers
Scientists found more than 100 possible cancer-causing mutations and defective alleles in a large-scale genetic analysis of pediatric cancers that was co-authored by Elizabeth Perlman, MD, and published in Nature.
Tracking Quality of Life During Prostate Cancer Treatment
Patients with advanced prostate cancer who received more intensive treatment experienced worse quality of life at three months, but better overall in the long-term, according to a new Northwestern Medicine study.